Community corner

    Article metrics

    • An Erratum to this article was published on 01 July 2008

    Access options

    Rent or Buy article

    Get time limited or full article access on ReadCube.

    from$8.99

    All prices are NET prices.

    References

    1. 1

      Kleinman, M.E., Yamada, Y. et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452, 591–597 (2008).

    Download references

    Ethics declarations

    Competing interests

    P.D.Z. is a cofounder and scientific advisor to Alnylam Pharmaceuticals and a scientific advisor to Regulus Therapeutics.

    Rights and permissions

    Reprints and Permissions

    About this article

    Further reading